Paydirt
DB
Insider

Daniel J. Brennan

EVP and CFO · Boston Scientific

Daniel J. Brennan (EVP and CFO) filed 3 Form 4 reports in the past 24 months (0 purchases, 3 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $8.9M of BSX (84,863 sh across 3 lots, as filed), executed Feb 18 2025. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$11.4M
shares × price, as filed
Last traded
Feb 19 2025
Filed Feb 19 2025

Median ADV $938.4M across their filed names

Open performance→
Volume by month
$10.5M$5.3M$0Dec 2024Jun 2025Dec 2025Jun 2026Jan 2025 · sells $871KFeb 2025 · sells $10.5M
Buys $0 Sells $11.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 24 months

Most traded names
BSX Boston Scientific Corporation BSX · 0 buys · 3 sells 3 filings
Recent filings
BSXSALE Boston Scientific Corporation View filing → $8.9M
84,863 sh across 3 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $1.6M
15,087 sh × $105.07
Exec Feb 12 2025
Filed Feb 13 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $871K
9,689 sh × $89.86
Exec Jan 3 2025
Filed Jan 3 2025 · 5:30 PM ET